Drug intelligence / Profile preview

zhijiangning

Development stage
Unknown
Lead developer
Hansen Pharmaceutical Company
Modality
Small Molecules
Administration
Oral
01

Overview

Zhijiangning (脂降宁) is an oral combination product containing both traditional Chinese medicinal (TCM) herbs and small molecule vitamins, developed and marketed by Baiyunshan Hansen (Guangzhou Baiyunshan Pharmaceutical). It is primarily indicated for the treatment of hyperlipidemia and the prevention of atherosclerosis. The formulation typically includes a blend of herbal extracts such as Hawthorn (Crataegus), Processed Polygonum multiflorum, Cassia seed, Lotus leaf, Alisma, Mulberry mistletoe, and Poria, supplemented with small molecules including Niacin (Nicotinic acid), Vitamin C (Ascorbic acid), and Vitamin B6 (Pyridoxine). Zhijiangning works through a multi-targeted approach: the herbal components are traditionally used to resolve phlegm and promote blood circulation to regulate lipid metabolism, while Niacin acts as an agonist of the G protein-coupled receptor GPR109A to inhibit lipolysis in adipose tissue, thereby reducing the synthesis of VLDL and LDL cholesterol.

Brand names
Zhijiangning Tablets脂降宁片
Other names
Zhijiangning Pian
02

Targets

HCAR2 (Hydroxycarboxylic acid receptor 2)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on zhijiangning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhijiangning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call